{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T04:51:07Z","timestamp":1749185467220,"version":"3.37.3"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82270200","No.82070203","No.81770210","No.82000195"],"award-info":[{"award-number":["No.82270200","No.82070203","No.81770210","No.82000195"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Research and Development Program of Shandong Province","doi-asserted-by":"crossref","award":["No.2018CXGC1213"],"award-info":[{"award-number":["No.2018CXGC1213"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Translational Research Grant of NCRCH","award":["No.2021WWB02","No.2020ZKMB01"],"award-info":[{"award-number":["No.2021WWB02","No.2020ZKMB01"]}]},{"name":"Taishan Scholars Program of Shandong Province"},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["No.ZR2020QH094"],"award-info":[{"award-number":["No.ZR2020QH094"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shandong Provincial Engineering Research Center of Lymphoma"},{"name":"Academic Promotion Programme of Shandong First Medical University","award":["No.2019QL018"],"award-info":[{"award-number":["No.2019QL018"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["No. 2022M721981"],"award-info":[{"award-number":["No. 2022M721981"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00109-023-02313-8","type":"journal-article","created":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T04:01:32Z","timestamp":1682913692000},"page":"595-606","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["PAX5 aberrant expression incorporated in MIPI-SP risk scoring system exhibits additive value in mantle cell lymphoma"],"prefix":"10.1007","volume":"101","author":[{"given":"Xin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Sui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueling","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8051-1481","authenticated-orcid":false,"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,1]]},"reference":[{"issue":"6","key":"2313_CR1","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/ajh.25487","volume":"94","author":"P Jain","year":"2019","unstructured":"Jain P, Wang M (2019) Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management. Am J Hematol 94(6):710\u2013725","journal-title":"Am J Hematol"},{"issue":"6","key":"2313_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3322\/caac.21357","volume":"66","author":"LR Teras","year":"2016","unstructured":"Teras LR, DeSantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR (2016) 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin 66(6):443\u2013459","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"2313_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.semcancer.2011.09.010","volume":"21","author":"KE Smedby","year":"2011","unstructured":"Smedby KE, Hjalgrim H (2011) Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes. Semin Cancer Biol 21(5):293\u2013298","journal-title":"Semin Cancer Biol"},{"key":"2313_CR4","doi-asserted-by":"crossref","unstructured":"Dreyling M, Campo E, Hermine O, Jerkeman M, Le Gouill S, Rule S, Shpilberg O, Walewski J, Ladetto M,\u00a0Committee EG (2017) Newly diagnosed and relapsed mantle cell lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals Oncol Off J Eur Soc Med Oncol 28(suppl_4):iv62\u2013iv71","DOI":"10.1093\/annonc\/mdx223"},{"issue":"13","key":"2313_CR5","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1200\/JCO.2013.52.2466","volume":"32","author":"E Hoster","year":"2014","unstructured":"Hoster E, Klapper W, Hermine O, Kluin-Nelemans HC, Walewski J, van Hoof A, Trneny M, Geisler CH, Di Raimondo F, Szymczyk M et al (2014) Confirmation of the mantle-cell lymphoma international prognostic index in randomized trials of the European Mantle-Cell Lymphoma Network. J Clin Oncol 32(13):1338\u20131346","journal-title":"J Clin Oncol"},{"issue":"2","key":"2313_CR6","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","volume":"111","author":"E Hoster","year":"2008","unstructured":"Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-Nelemans HC, Pfreundschuh M, Reiser M, Metzner B, Einsele H et al (2008) A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood 111(2):558\u2013565","journal-title":"Blood"},{"issue":"4","key":"2313_CR7","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00432-017-2570-8","volume":"144","author":"X Yan","year":"2018","unstructured":"Yan X, Zhou Y, Huang S, Li X, Yu M, Huang J, Wang J, Ma Z, Jin J, Pan J et al (2018) Promising efficacy of novel BTK inhibitor AC0010 in mantle cell lymphoma. J Cancer Res Clin Oncol 144(4):697\u2013706","journal-title":"J Cancer Res Clin Oncol"},{"issue":"12","key":"2313_CR8","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1182\/blood.2020005289","volume":"136","author":"F Nadeu","year":"2020","unstructured":"Nadeu F, Martin-Garcia D, Clot G, D\u00edaz-Navarro A, Duran-Ferrer M, Navarro A, Vilarrasa-Blasi R, Kulis M, Royo R, Guti\u00e9rrez-Abril J et al (2020) Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes. Blood 136(12):1419\u20131432","journal-title":"Blood"},{"key":"2313_CR9","doi-asserted-by":"crossref","unstructured":"Yi S, Yan Y, Jin M, Bhattacharya S, Wang Y, Wu Y, Yang L, Gine E, Clot G, Chen L et al (2022) Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma. J Clin Investig 132(3)","DOI":"10.1172\/JCI153283"},{"key":"2313_CR10","doi-asserted-by":"crossref","unstructured":"Rule S, Dreyling M, Goy A, Hess G, Auer R, Kahl B, Hernandez-Rivas JA, Qi K, Deshpande S, Parisi L et al (2019) Ibrutinib for the treatment of relapsed\/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis. Haematologica\u00a0104(5):e211\u2013e214","DOI":"10.3324\/haematol.2018.205229"},{"key":"2313_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/B978-0-12-385991-4.00005-2","volume":"111","author":"J Medvedovic","year":"2011","unstructured":"Medvedovic J, Ebert A, Tagoh H, Busslinger M (2011) Pax5: a master regulator of B cell development and leukemogenesis. Adv Immunol 111:179\u2013206","journal-title":"Adv Immunol"},{"key":"2313_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.153810","volume":"231","author":"L Zheng","year":"2022","unstructured":"Zheng L, He J, Li M, Yuan H, Li H, Hu F, Chen L, Tang W, Sheng M (2022) Clinical significance and mechanism of long noncoding RNA HAGLROS in triple negative breast cancer. Pathol Res Pract 231:153810","journal-title":"Pathol Res Pract"},{"issue":"9","key":"2313_CR13","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.3889\/oamjms.2018.269","volume":"6","author":"MK Haghverdi","year":"2018","unstructured":"Haghverdi MK, Moslemi E (2018) Expression rate and PAX5 gene methylation in the blood of people suffering from gastric cancer. Open Access Maced J Med Sci 6(9):1571\u20131576","journal-title":"Open Access Maced J Med Sci"},{"issue":"11","key":"2313_CR14","first-page":"14709","volume":"8","author":"Y Ren","year":"2015","unstructured":"Ren Y, Hou J, Xu A, Pan Y (2015) Diagnostic utility of PAX2 and PAX5 in distinguishing non-small cell lung cancer from small cell lung cancer. Int J Clin Exp Pathol 8(11):14709\u201314716","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"2313_CR15","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41419-019-1932-3","volume":"10","author":"N Zhang","year":"2019","unstructured":"Zhang N, Li Z, Bai F, Zhang S (2019) PAX5-induced upregulation of IDH1-AS1 promotes tumor growth in prostate cancer by regulating ATG5-mediated autophagy. Cell Death Dis 10(10):734","journal-title":"Cell Death Dis"},{"issue":"1","key":"2313_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.18632\/aging.203828","volume":"14","author":"D Sun","year":"2022","unstructured":"Sun D, Li F, Liu L, Yu S, Wang H, Gao X, Liu G, Zhao Y, Qiu G, Jiang X (2022) PSMA3-AS1 induced by transcription factor PAX5 promotes cholangiocarcinoma proliferation, migration and invasion by sponging miR-376a-3p to up-regulate LAMC1. Aging 14(1):509\u2013525","journal-title":"Aging"},{"key":"2313_CR17","doi-asserted-by":"crossref","unstructured":"Calder\u00f3n L, Schindler K, Malin SG, Schebesta A, Sun Q, Schwickert T, Alberti C, Fischer M, Jaritz M, Tagoh H et al (2021)\u00a0Pax5 regulates B cell immunity by promoting PI3K signaling via PTEN down-regulation. Sci Immunol\u00a06(61)","DOI":"10.1126\/sciimmunol.abg5003"},{"key":"2313_CR18","unstructured":"National Comprehensive Cancer Network. (NCCN) Clinical Practice Guidelines in Oncology. B-cell lymphomas, Version 2.2022. https:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp. Accessed 21 Mar 2022"},{"issue":"1","key":"2313_CR19","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK (2019) Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 10(1):1523","journal-title":"Nat Commun"},{"issue":"7","key":"2313_CR20","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1080\/10428194.2016.1248965","volume":"58","author":"N Vogt","year":"2017","unstructured":"Vogt N, Dai B, Erdmann T, Berdel WE, Lenz G (2017) The molecular pathogenesis of mantle cell lymphoma. Leuk Lymphoma 58(7):1530\u20131537","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2313_CR21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00428-015-1840-6","volume":"468","author":"B Sander","year":"2016","unstructured":"Sander B, Quintanilla-Martinez L, Ott G, Xerri L, Kuzu I, Chan JK, Swerdlow SH, Campo E (2016) Mantle cell lymphoma\u2013a spectrum from indolent to aggressive disease. Virchows Archiv An Int J Pathol 468(3):245\u2013257","journal-title":"Virchows Archiv An Int J Pathol"},{"issue":"1","key":"2313_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1158\/1078-0432.CCR-20-2868","volume":"27","author":"S Demajo","year":"2021","unstructured":"Demajo S, Albero R, Clot G, Castellano G, Navarro A, Capdevila C, Enjuanes A, Nadeu F, Gine E, Pinyol M et al (2021) A cyclin D1-dependent transcriptional program predicts clinical outcome in mantle cell lymphoma. Clin Cancer Res An Off J Am Assoc Cancer Res 27(1):213\u2013225","journal-title":"Clin Cancer Res An Off J Am Assoc Cancer Res"},{"issue":"15","key":"2313_CR23","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1200\/JCO.2016.70.7901","volume":"35","author":"DW Scott","year":"2017","unstructured":"Scott DW, Abrisqueta P, Wright GW, Slack GW, Mottok A, Villa D, Jares P, Rauert-Wunderlich H, Royo C, Clot G et al (2017) New molecular assay for the proliferation signature in mantle cell lymphoma applicable to formalin-fixed paraffin-embedded biopsies. J Clin Oncol Off J Am Soc Clin Oncol 35(15):1668\u20131677","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"4","key":"2313_CR24","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00432-020-03125-w","volume":"146","author":"DM Xu","year":"2020","unstructured":"Xu DM, Liang JH, Wang L, Zhu HY, Xia Y, Fan L, Li JY, Xu W (2020) 25-Hydroxy vitamin D deficiency predicts inferior prognosis in mantle cell lymphoma. J Cancer Res Clin Oncol 146(4):1003\u20131009","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"2313_CR25","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1084\/jem.138.6.1608","volume":"138","author":"HM Grey","year":"1973","unstructured":"Grey HM, Kubo RT, Colon SM, Poulik MD, Cresswell P, Springer T, Turner M, Strominger JL (1973) The small subunit of HL-A antigens is beta 2-microglobulin. J Exp Med 138(6):1608\u20131612","journal-title":"J Exp Med"},{"issue":"3","key":"2313_CR26","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3109\/10428194.2014.917640","volume":"56","author":"C Yoo","year":"2015","unstructured":"Yoo C, Yoon DH, Yoon S, Kim S, Huh J, Park CJ, Lee SW, Suh C (2015) Prognostic impact of beta(2)-microglobulin in patients with non-gastric mucosa-associated lymphoid tissue lymphoma. Leuk Lymphoma 56(3):688\u2013693","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2313_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.5045\/br.2014.49.3.148","volume":"49","author":"C Yoo","year":"2014","unstructured":"Yoo C, Yoon DH, Suh C (2014) Serum beta-2 microglobulin in malignant lymphomas: an old but powerful prognostic factor. Blood Res 49(3):148\u2013153","journal-title":"Blood Res"},{"key":"2313_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.humpath.2019.04.010","volume":"89","author":"A Saksena","year":"2019","unstructured":"Saksena A, Yin CC, Xu J, Li J, Zhou J, Wang SA, Lin P, Tang G, Wang L, Wang M et al (2019) CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis. Hum Pathol 89:71\u201380","journal-title":"Hum Pathol"},{"key":"2313_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev-immunol-032712-100024","volume":"32","author":"EV Rothenberg","year":"2014","unstructured":"Rothenberg EV (2014) Transcriptional control of early T and B cell developmental choices. Annu Rev Immunol 32:283\u2013321","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"2313_CR30","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1172\/JCI30842","volume":"117","author":"D Cozma","year":"2007","unstructured":"Cozma D, Yu D, Hodawadekar S, Azvolinsky A, Grande S, Tobias JW, Metzgar MH, Paterson J, Erikson J, Marafioti T et al (2007) B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling. J Clin Investig 117(9):2602\u20132610","journal-title":"J Clin Investig"},{"issue":"6","key":"2313_CR31","first-page":"2528","volume":"25","author":"HR Song","year":"2021","unstructured":"Song HR, Guo XB, Duan Y, Meng HY, Wang ZY (2021) PAX5-induced upregulation of LINC01194 exerts oncogenic properties by regulating GOLPH3 expression via miR-486-5p in prostate cancer. Eur Rev Med Pharmacol Sci 25(6):2528\u20132541","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7","key":"2313_CR32","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41419-019-1699-6","volume":"10","author":"X Wu","year":"2019","unstructured":"Wu X, Xiao Y, Zhou Y, Zhou Z, Yan W (2019) LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4. Cell Death Dis 10(7):472","journal-title":"Cell Death Dis"},{"issue":"11","key":"2313_CR33","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1242\/jcs.183889","volume":"129","author":"D Wang","year":"2016","unstructured":"Wang D, Chen J, Li R, Wu G, Sun Z, Wang Z, Zhai Z, Fang F, Guo Y, Zhong Y et al (2016) PAX5 interacts with RIP2 to promote NF-kappaB activation and drug-resistance in B-lymphoproliferative disorders. J Cell Sci 129(11):2261\u20132272","journal-title":"J Cell Sci"},{"key":"2313_CR34","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/978-0-387-69080-3_49","volume":"617","author":"CM Vouyovitch","year":"2008","unstructured":"Vouyovitch CM, Vidal L, Borges S, Raccurt M, Arnould C, Chiesa J, Lobie PE, Lachuer J, Mertani HC (2008) Proteomic analysis of autocrine\/paracrine effects of human growth hormone in human mammary carcinoma cells. Adv Exp Med Biol 617:493\u2013500","journal-title":"Adv Exp Med Biol"},{"issue":"7161","key":"2313_CR35","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nature06159","volume":"449","author":"C Cobaleda","year":"2007","unstructured":"Cobaleda C, Jochum W, Busslinger M (2007) Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature 449(7161):473\u2013477","journal-title":"Nature"},{"issue":"1","key":"2313_CR36","doi-asserted-by":"publisher","first-page":"22919","DOI":"10.1038\/s41598-021-02082-9","volume":"11","author":"K Hosokawa","year":"2021","unstructured":"Hosokawa K, Ishimaru H, Watanabe T, Fujimuro M (2021) Pax5 mediates the transcriptional activation of the CD81 gene. Sci Rep 11(1):22919","journal-title":"Sci Rep"},{"issue":"5","key":"2313_CR37","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrc3035","volume":"11","author":"P Ranganathan","year":"2011","unstructured":"Ranganathan P, Weaver KL, Capobianco AJ (2011) Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer 11(5):338\u2013351","journal-title":"Nat Rev Cancer"},{"issue":"20","key":"2313_CR38","doi-asserted-by":"publisher","first-page":"29804","DOI":"10.18632\/oncotarget.7772","volume":"7","author":"Y Gu","year":"2016","unstructured":"Gu Y, Masiero M, Banham AH (2016) Notch signaling: its roles and therapeutic potential in hematological malignancies. Oncotarget 7(20):29804\u201329823","journal-title":"Oncotarget"},{"issue":"1","key":"2313_CR39","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s13046-019-1458-7","volume":"38","author":"E Silkenstedt","year":"2019","unstructured":"Silkenstedt E, Arenas F, Colom-Sanmart\u00ed B, Xargay-Torrent S, Higashi M, Gir\u00f3 A, Rodriguez V, Fuentes P, Aulitzky WE, van der Kuip H et al (2019) Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy. J Exp Clin Cancer Res 38(1):446","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"2313_CR40","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/jcmm.12768","volume":"20","author":"L Zhao","year":"2016","unstructured":"Zhao L, Li S, Gan L, Li C, Qiu Z, Feng Y, Li J, Li L, Li C, Peng W et al (2016) Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering beta-catenin signalling and GADD45G expression. J Cell Mol Med 20(5):842\u2013854","journal-title":"J Cell Mol Med"},{"issue":"2","key":"2313_CR41","doi-asserted-by":"publisher","first-page":"498","DOI":"10.7150\/ijbs.55636","volume":"17","author":"SL Liu","year":"2021","unstructured":"Liu SL, Cai C, Yang ZY, Wu ZY, Wu XS, Wang XF, Dong P, Gong W (2021) DGCR5 is activated by PAX5 and promotes pancreatic cancer via targeting miR-3163\/TOP2A and activating Wnt\/beta-catenin pathway. Int J Biol Sci 17(2):498\u2013513","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2313_CR42","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1186\/s12967-021-03089-6","volume":"19","author":"H Ji","year":"2021","unstructured":"Ji H, Song H, Wang Z, Jiao P, Xu J, Li X, Du H, Wu H, Zhong Y (2021) FAM83A promotes proliferation and metastasis via Wnt\/beta-catenin signaling in head neck squamous cell carcinoma. J Transl Med 19(1):423","journal-title":"J Transl Med"},{"issue":"1","key":"2313_CR43","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1186\/s12967-021-03087-8","volume":"19","author":"Q Wang","year":"2021","unstructured":"Wang Q, Xu J, Xiong Z, Xu T, Liu J, Liu Y, Chen J, Shi J, Shou Y, Yue C et al (2021) CENPA promotes clear cell renal cell carcinoma progression and metastasis via Wnt\/beta-catenin signaling pathway. J Transl Med 19(1):417","journal-title":"J Transl Med"},{"issue":"14","key":"2313_CR44","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1038\/s41388-020-1183-x","volume":"39","author":"G Lazarian","year":"2020","unstructured":"Lazarian G, Friedrich C, Quinquenel A, Tran J, Ouriemmi S, Dondi E, Martin A, Mihoub I, Chiron D, Bellanger C et al (2020) Stabilization of beta-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma. Oncogene 39(14):2934\u20132947","journal-title":"Oncogene"},{"issue":"6","key":"2313_CR45","first-page":"2986","volume":"24","author":"W Wang","year":"2020","unstructured":"Wang W, Wang Z, Wang H, Li X, Wang HT (2020) Promoting effect of PAX5-activated lncRNA UASR1 on growth of colorectal cancer by regulating the mTOR pathway. Eur Rev Med Pharmacol Sci 24(6):2986\u20132993","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"11","key":"2313_CR46","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1080\/10428194.2019.1607326","volume":"60","author":"GA Ferreira","year":"2019","unstructured":"Ferreira GA, Thome CH, Simao AMS, Scheucher PS, Silva CLA, Chahud F, Ciancaglini P, Leopoldino AM, Rego EM, Faca VM et al (2019) The lipid raft protein NTAL participates in AKT signaling in mantle cell lymphoma. Leuk Lymphoma 60(11):2658\u20132668","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"2313_CR47","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1182\/blood-2012-06-438937","volume":"121","author":"MC Vegliante","year":"2013","unstructured":"Vegliante MC, Palomero J, Perez-Galan P, Roue G, Castellano G, Navarro A, Clot G, Moros A, Suarez-Cisneros H, Bea S et al (2013) SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma. Blood 121(12):2175\u20132185","journal-title":"Blood"},{"issue":"1","key":"2313_CR48","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1186\/s12885-020-07678-4","volume":"20","author":"L Lokhande","year":"2020","unstructured":"Lokhande L, Kuci Emruli V, Kolstad A, Hutchings M, Raty R, Jerkeman M, Ek S (2020) Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk. BMC Cancer 20(1):1202","journal-title":"BMC Cancer"},{"issue":"12","key":"2313_CR49","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1007\/s11427-015-4919-z","volume":"58","author":"C Huang","year":"2015","unstructured":"Huang C, Melnick A (2015) Mechanisms of action of BCL6 during germinal center B cell development. Sci China Life Sci 58(12):1226\u20131232","journal-title":"Sci China Life Sci"},{"issue":"7","key":"2313_CR50","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1038\/leu.2015.355","volume":"30","author":"J Palomero","year":"2016","unstructured":"Palomero J, Vegliante MC, Eguileor A, Rodriguez ML, Balsas P, Martinez D, Campo E, Amador V (2016) SOX11 defines two different subtypes of mantle cell lymphoma through transcriptional regulation of BCL6. Leukemia 30(7):1596\u20131599","journal-title":"Leukemia"},{"issue":"6","key":"2313_CR51","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1158\/0008-5472.CAN-04-1526","volume":"65","author":"L Hern\u00e1ndez","year":"2005","unstructured":"Hern\u00e1ndez L, Be\u00e0 S, Pinyol M, Ott G, Katzenberger T, Rosenwald A, Bosch F, L\u00f3pez-Guillermo A, Delabie J, Colomer D et al (2005) CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a\/ARF locus. Can Res 65(6):2199\u20132206","journal-title":"Can Res"},{"issue":"4","key":"2313_CR52","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3324\/haematol.10891","volume":"92","author":"E Hartmann","year":"2007","unstructured":"Hartmann E, Fern\u00e0ndez V, Stoecklein H, Hern\u00e1ndez L, Campo E, Rosenwald A (2007) Increased MDM2 expression is associated with inferior survival in mantle-cell lymphoma, but not related to the MDM2 SNP309. Haematologica 92(4):574\u2013575","journal-title":"Haematologica"},{"issue":"2","key":"2313_CR53","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1182\/blood-2010-02-269514","volume":"117","author":"P Perez-Galan","year":"2011","unstructured":"Perez-Galan P, Mora-Jensen H, Weniger MA, Shaffer AL 3rd, Rizzatti EG, Chapman CM, Mo CC, Stennett LS, Rader C, Liu P et al (2011) Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation. Blood 117(2):542\u2013552","journal-title":"Blood"},{"issue":"1","key":"2313_CR54","doi-asserted-by":"publisher","first-page":"77","DOI":"10.21873\/cgp.20169","volume":"17","author":"T Tsukamoto","year":"2020","unstructured":"Tsukamoto T, Nakahata S, Sato R, Kanai A, Nakano M, Chinen Y, Maegawa-Matsui S, Matsumura-Kimoto Y, Takimoto-Shimomura T, Mizuno Y et al (2020) BRD4-regulated molecular targets in mantle cell lymphoma: insights into targeted therapeutic approach. Cancer Genom Proteom 17(1):77\u201389","journal-title":"Cancer Genom Proteom"},{"key":"2313_CR55","doi-asserted-by":"crossref","unstructured":"Chen YH, Gao J, Fan G, Peterson LC (2010) Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms. Mod Pathol An Off J US Can Acad Pathol Inc 23(1):105\u2013112","DOI":"10.1038\/modpathol.2009.140"},{"issue":"5","key":"2313_CR56","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1600-0609.2012.01837.x","volume":"89","author":"KH Hamborg","year":"2012","unstructured":"Hamborg KH, Bentzen HH, Grubach L, Hokland P, Nyvold CG (2012) A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma. Eur J Haematol 89(5):385\u2013394","journal-title":"Eur J Haematol"},{"issue":"20","key":"2313_CR57","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.1158\/0008-5472.CAN-12-1615","volume":"72","author":"A Navarro","year":"2012","unstructured":"Navarro A, Clot G, Royo C, Jares P, Hadzidimitriou A, Agathangelidis A, Bikos V, Darzentas N, Papadaki T, Salaverria I et al (2012) Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features. Cancer Res 72(20):5307\u20135316","journal-title":"Cancer Res"},{"issue":"1","key":"2313_CR58","doi-asserted-by":"publisher","first-page":"11896","DOI":"10.1038\/s41598-021-91433-7","volume":"11","author":"C Jing","year":"2021","unstructured":"Jing C, Zheng Y, Feng Y, Cao X, Xu C (2021) Prognostic significance of p53, Sox11, and Pax5 co-expression in mantle cell lymphoma. Sci Rep 11(1):11896","journal-title":"Sci Rep"},{"issue":"3","key":"2313_CR59","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/leu.2015.140","volume":"30","author":"AE Teo","year":"2016","unstructured":"Teo AE, Chen Z, Miranda RN, McDonnell T, Medeiros LJ, McCarty N (2016) Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1. Leukemia 30(3):580\u2013593","journal-title":"Leukemia"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-023-02313-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-023-02313-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-023-02313-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T14:31:38Z","timestamp":1729348298000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-023-02313-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["2313"],"URL":"https:\/\/doi.org\/10.1007\/s00109-023-02313-8","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"type":"print","value":"0946-2716"},{"type":"electronic","value":"1432-1440"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"12 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethical Committee of Shandong Provincial Hospital affiliated to Shandong University. All samples of patients were obtained with informed consent in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}